McMaster researchers are collaborating in a major nationwide study on the effectiveness of COVID-19 vaccines in people with immune-mediated inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease and psoriasis.
More than 90 per cent of residents in long-term care facilities created an initial immune response after two doses of COVID-19 vaccine, and researchers recommend third-dose boosters be provided immediately.
McMaster experts joined the Lung Health Foundation to answer community questions around COVID-19 vaccines.
McMaster logo
McMaster logo
